Does Migraine with Aura Require Different Treatment Strategies Compared to Migraine Without Aura?

INTRODUCTION

Migraine has two foremost varieties: migraine with aura (MwA) and migraine with out aura (MwoA).¹ The previous is much less frequent and solely impacts round 30% of sufferers with migraine.² Even in those that expertise aura, these signs have a tendency to not accompany each assault.³ Rarer nonetheless are the genetic types of MwA, resembling familial hemiplegic migraine, which may pose a selected diagnostic and therapeutic problem, as aura tends to be significantly disabling and extended in these affected.⁴

Worldwide migraine remedy pointers don’t set up important distinctions between the preventive and acute remedy of MwA and MwoA, adopting a typically unified therapeutic strategy.⁵ This uniformity of follow, while pragmatic, can also be in line with rising proof, largely mechanistic, for a dissociation between the aura and the headache phases of the migraine assault;⁶ subsequently, therapies which can be focused at headache, or headache prevention, ought to, a minimum of in idea, be thought of constantly efficacious throughout MwA and MwoA. Remedy or prevention of problematic aura signs within the minority of sufferers in whom these are current poses a separate problem, and thus far no RCTs have been revealed that particularly consider aura-targeted therapies on this affected person subset. A abstract of the comparisons between MwA and MwoA is proven in Desk 1.

BIOLOGICAL MECHANISMS

Biologically, cortical spreading melancholy (CSD) is deemed a possible electrophysiological substrate of the migraine aura.⁷ In animal fashions, CSD can activate the trigeminovascular system and meningeal nociceptors.⁸ Human neuroimaging research have proven modifications in cerebral blood circulate and blood-oxygen-level dependent sign throughout aura, supporting CSD as a believable substrate, which can then hyperlink cortical occasions to subsequent trigeminovascular activation.^7,9 Nonetheless, CSD and trigeminal nociception aren’t obligatorily coupled; aura can happen with out subsequent headache, and headache with no previous aura.⁸ This temporal dissociation, the truth that nearly all of sufferers with migraine have MwoA, and the truth that those that expertise aura sometimes have extra assaults with out aura than with, assist clarify why MwA and MwoA share broadly related remedy methods, because the headache itself seems to come up by means of trigeminovascular activation, whether or not or not an aura is symptomatically current. The exact mechanistic and temporal relationships between CSD and headache technology in people, whereas more and more supported by imaging proof, aren’t but totally resolved. A abstract of doable hyperlinks between the processes is proven in Determine 1.

TREATMENT

Some brokers that act on CSD might, on mechanistic grounds, supply better profit in MwA, though this concept rests on pathophysiological plausibility relatively than direct scientific proof, and it  stays debated whether or not CSD happens in an asymptomatic type in silent cortex in sufferers who by no means expertise aura,¹⁰ or certainly in these with MwA who even have assaults with out accompanying aura. Imaging research counsel an aura ‘trait’ throughout the occipital cortex in sufferers with MwA no matter whether or not aura is symptomatically current, pointing to a genetic vulnerability of this mind space on this affected person group.¹¹ Single-pulse transcranial magnetic stimulation (sTMS) inhibits CSD in animals,¹² and, in a randomised sham-controlled trial, was an efficient choice for the acute remedy of MwA through neuromodulation of the occipital cortex.¹³ Magnesium could also be helpful in MwA, presumably by means of N-methyl-D-aspartate (NMDA) antagonism, each within the acute part, together with termination of extended aura,¹⁴ and in migraine prevention.¹⁵

Nonetheless, intravenous magnesium can paradoxically and anecdotally worsen headache in some sufferers (though there isn’t any robust revealed proof that magnesium instantly worsens migraine in a reproducible subset of sufferers), and proof for an aura-specific profit is proscribed to small case sequence and open-label information relatively than managed trials. Gastrointestinal unwanted effects can complicate remedy. Amongst NMDA receptor antagonists, memantine has additionally been reported, in uncontrolled information, to cut back aura,¹⁶ and is utilized in some settings for migraine prevention.¹⁷ Within the authors’ expertise, they’re extra prone to supply flunarizine¹⁸ or memantine in sufferers with problematic aura. sTMS will not be extensively out there in most scientific settings. The protection of triptans in MwA stays debated. Within the authors’ follow, they keep away from them in sufferers with extended or complicated aura (resembling hemiplegic or brainstem aura), however are much less cautious when typical aura is current and lasts lower than an hour.

In scientific follow, there are subsequently frequent themes in managing MwA and MwoA, though a couple of particular concerns exist in MwA. These embody the modestly elevated stroke threat in MwA, particularly in younger ladies who’re people who smoke and/or utilizing oestrogen-containing contraceptives. Co-existing vascular comorbidities like hypertension might contribute to this threat in these affected. New or extended aura, aura with out headache, and related atypical neurological options (an abrupt onset with the deficit maximal symptom depth from the onset, predominantly destructive signs, related fever, altered psychological standing, or focal neurological deficit) are amongst a few of the pink flags when evaluating a affected person with headache, and will immediate investigation for different causes resembling ischaemic stroke or transient ischaemic assault. In observational and meta-analytic information, MwA is a longtime unbiased threat issue for ischaemic stroke, reflecting shared vascular pathophysiology and a few overlapping threat components between aura and stroke.¹⁹ A central speculation is that CSD induces focal oligaemia that may progress to infarction in neural tissue with a genetic or metabolic predisposition. The aura part additionally seems to launch inflammatory cytokines. These set off endothelial activation, oxidative stress, and a systemic prothrombotic state.¹⁹ In ladies with MwA, observational information point out that mixed hormonal contraceptives improve stroke threat synergistically, significantly in people who smoke.²⁰ Present pointers from main medical societies subsequently contraindicate or advocate in opposition to their use on this inhabitants.²¹ While latest large-scale observational research counsel that trendy low-dose formulations of mixed hormonal contraceptives might carry decrease absolute stroke threat than beforehand estimated,²² these findings stay inadequate to alter present suggestions. Shared decision-making that fastidiously weighs particular person cardiovascular threat components, age-related absolute threat, and different contraceptive choices stays important when counselling ladies with MwA about contraception. Smoking is a significant modifiable contributor to ischaemic stroke threat on this group, and its cessation ought to be actively inspired as a precedence in decreasing that threat.

NOVEL THERAPIES

The most recent medicine in scientific follow for migraine are the calcitonin gene-related peptide (CGRP)-targeted therapies, which comprise the preventive CGRP monoclonal antibodies (mAbs) and the acute and preventive small-molecule CGRP receptor antagonists (gepants). Though CGRP mAbs successfully cut back migraine frequency, their giant molecular measurement limits penetration throughout the blood–mind barrier, so their main website of motion has been considered predominantly peripheral. Nonetheless, preliminary information counsel that some cerebrospinal fluid penetration happens.²³ Accordingly, preclinical proof signifies that mAbs in all probability don’t forestall the initiation of CSD itself, however might modulate it by attenuating the following trigeminovascular sensitisation.²⁴ In animal fashions, gepants can also modulate CSD with out blocking its initiation,²⁵ though they might penetrate the blood–mind barrier at greater concentrations than mAbs.²⁶ Gepants have a extra beneficial vascular profile than triptans and mAbs, owing to their lack of vasoconstrictive properties, quick half-lives, and reversible receptor antagonism. In contrast to triptans, they don’t sometimes elevate blood stress. The acute remedy of the headache is equally unaffected by aura standing: triptans taken throughout the aura, earlier than ache onset, neither forestall nor delay the following headache,²⁷ confirming that the aura gives no window for earlier abortive remedy in research thus far. Additional research evaluating gepants administered throughout aura might comply with, as latest proof suggests efficacy when taken throughout the migraine prodrome for stopping subsequent headache.²⁸ For sufferers with complicated or extended aura, the non-vasoconstrictive profile of gepants makes them an affordable different to triptans; right here the related consideration is vascular relatively than temporal. Future analysis ought to make clear how these novel therapies affect CSD, and subsequently aura, in order that remedy might be directed at neuronal mechanisms relatively than chosen on vascular grounds alone.

CONCLUSION

Regardless of the mechanistic and scientific options that set MwA aside, its remedy stays, for now, largely indistinguishable from that of MwoA. This shared strategy is pragmatic and has a mechanistic rationale: the headache seems to come up by means of trigeminovascular activation no matter migraine subtype, and the newer, mechanism-specific therapies had been examined in trials that mixed MwA and MwoA, and weren’t powered to detect variations between them. The aura itself is the exception, with no evidence-based focused remedy of its personal. Traditionally, now we have relied on non-specific brokers developed for different indications for migraine remedy, and unwanted effects and poor tolerability have prompted affected person and doctor frustration and delayed satisfactory management. CGRP-targeted therapies have began to alter the panorama for each acute and preventive migraine remedy, however their worth in MwA in contrast with MwoA stays at present undefined, as does their relationship to CSD, a course of that seems distinct from, and maybe parallel to, trigeminovascular activation. Progress in direction of therapies tailor-made to MwA will rely on a number of advances within the present period: clarifying how CGRP-targeted therapies act on CSD, and whether or not this brings any subtype-specific profit; and creating therapies aimed on the aura itself, by testing their impact on each the aura and any headache that follows. Designing trials that stratify sufferers by phenotype relatively than combining all heterogeneous sufferers collectively, with endpoints and biomarkers in a position to separate aura from ache mechanisms, will seemingly contribute to our understanding of any elementary organic variations between MwA and MwoA going forwards. Till these questions are answered, remedy for the time being can’t be usefully personalised to migraine phenotype broadly within the absence of aura-specific remedy proof. Hopefully, sooner or later, advances in human neuroimaging, organic and treatment-related biomarkers, and additional understanding of the position of CGRP and different neuropeptides like pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38) in aura, will permit us to higher handle the at present underserved MwA affected person group.